These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11070848)

  • 1. Cell proliferation markers in human solid tumors: assessing their impact in clinical oncology.
    Daidone MG; Costa A; Silvestrini R
    Methods Cell Biol; 2001; 64():359-84. PubMed ID: 11070848
    [No Abstract]   [Full Text] [Related]  

  • 2. Proliferation markers in tumours: interpretation and clinical value.
    van Diest PJ; Brugal G; Baak JP
    J Clin Pathol; 1998 Oct; 51(10):716-24. PubMed ID: 10023332
    [No Abstract]   [Full Text] [Related]  

  • 3. New prognostic factors in resectable non-small cell lung cancer.
    Smit EF; Groen HJ; Splinter TA; Ebels T; Postmus PE
    Thorax; 1996 Jun; 51(6):638-46. PubMed ID: 8693450
    [No Abstract]   [Full Text] [Related]  

  • 4. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
    Camplejohn RS; Brock A; Barnes DM; Gillett C; Raikundalia B; Kreipe H; Parwaresch MR
    Br J Cancer; 1993 Apr; 67(4):657-62. PubMed ID: 7682430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of proliferation rates to prognosis in human renal cell carcinoma.
    de Riese W; Allhoff EP; Liedke S; Lenis G; Stief CG; Werner M; Atzpodien J; Kirchner H
    Eur J Cancer; 1993; 29A(7):1072-3. PubMed ID: 8499141
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
    Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
    Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers of prognosis in invasive bladder cancer.
    Fradet Y
    Semin Oncol; 1990 Oct; 17(5):533-43. PubMed ID: 2218565
    [No Abstract]   [Full Text] [Related]  

  • 8. [The application of cytofluorometry to solid tumors for measuring DNA and the S phase].
    Brugarolas A; Pardo-Mindán FJ
    Med Clin (Barc); 1993 Dec; 101(19):750-6. PubMed ID: 8289525
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
    J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of cellular kinetics as a predictive index of response to radiotherapy: state of the art and future perspectives].
    Sannazzari GL
    Radiol Med; 1993 Sep; 86(3):322-6. PubMed ID: 8210542
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of the prevention of oral cancer and diagnostic markers of malignant change: 2. Markers of value in tumour diagnosis.
    Macluskey M; Ogden GR
    Dent Update; 2000 Apr; 27(3):148-52. PubMed ID: 11218286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser cytometry of human tissues and tumors: proliferation and therapeutic applications.
    Rew DA
    Methods Cell Biol; 2001; 64():445-86. PubMed ID: 11070851
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human tumors by laser scanning cytometry.
    Gorczyca W; Deptala A; Bedner E; Li X; Melamed MR; Darzynkiewicz Z
    Methods Cell Biol; 2001; 64():421-43. PubMed ID: 11070850
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cytophotometric characteristics to histology and proliferation markers in acoustic neuromas.
    Welkoborsky HJ; Haibt G; Mann WJ; Amedee RG
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):49-53. PubMed ID: 7904813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic specific antigen.
    Shearer RJ
    Br J Urol; 1991 Jan; 67(1):1-5. PubMed ID: 1704275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Markers of proliferation and morpho-immunologic parameters in evaluation of prognostic factors in endometrial tumors].
    Kedzia W; Rutkowski R; Jankowska A; Spaczyński M; Kedzia H
    Ginekol Pol; 1997 Apr; 68(4):199-205. PubMed ID: 9463085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When to use Ki67].
    Scoazec JY
    Ann Pathol; 2011 Nov; 31(5 Suppl):S52-4. PubMed ID: 22054460
    [No Abstract]   [Full Text] [Related]  

  • 20. The identification of informative parameters in the flow cytometric analysis of breast carcinoma.
    Lawry J; Rogers K; Duncan JL; Potter CW
    Eur J Cancer; 1993; 29A(5):719-23. PubMed ID: 8471330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.